Nikita Shah, Executive Vice President at Amneal Pharmaceuticals, Inc. (AMRX), sold 146,403 shares at $17.51 ($2.6M) on 2026-08-12, disclosed to the SEC on 2026-08-13.
Open-market sale of $2.6M AMRX by Executive Vice President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| AMRX | SELL | 2025-08-15 | $1.3M | — | Filing → |
| AMRX | SELL | 2025-08-13 | $904K | — | Filing → |
| AMRX | SELL | 2025-05-19 | $745K | — | Filing → |